EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) — As the first wave of gene therapies for transfusion-dependent B-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within the hematology community: whether the future belongs to gene editing or gene addition. Recent physician survey data from Market DynamixTM: Transfusion-Dependent Thalassemia reveal […]

“We wanted to create an improved way to access wet wipes for increased sanitation when using the bathroom,” said an inventor, from Bellevue, Wash., “so we invented the CLEAN ROLL. Our design could contribute to better hygiene techniques, and it prevents the wet wipes from drying out.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The invention provides an improved way to

Which Gene Therapy Technology Wins? New Data from Spherix Global Insights Reveals Emerging Hematologist Preferences in Beta Thalassemia Care New research from Spherix Global Insights reveal Vertex/CRISPR Therapeutics' Casgevy holding a competitive edge over bluebird bio's Zynteglo as preferred beta thalassemia gene therapies. GlobeNewswire August 14, 2025 EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) —

(NYSE:DV),(NASDAQ:FLYW),(NYSE:IBTA),(NASDAQ:SMTC), PHILADELPHIA, Aug. 14, 2025 (GLOBE NEWSWIRE) — DoubleVerify Holdings, Inc. (NYSE: DV): Grabar Law Office is investigating whether certain officers and directors of DoubleVerify Holdings, Inc. (NYSE: DV) breached their fiduciary duties owed to the company. If you have held DoubleVerify Holdings, Inc. (NYSE: DV) shares since prior to November 10, 2023, and would

Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Flywire Corporation (NASDAQ: FLYW); Ibotta, Inc. (NYSE: IBTA); and Semtech Corporation: Grabar Law Office is Investigating Claims on Your Behalf GlobeNewswire August 14, 2025 PHILADELPHIA, Aug. 14, 2025 (GLOBE NEWSWIRE) — DoubleVerify Holdings, Inc. (NYSE: DV): Grabar Law Office is investigating whether certain officers

Grand Prize Awarded toQuivly AI in National Veteran-Led Startup Event VetsinTech, the leading national nonprofit dedicated to supporting U.S. veterans through tech-based programs and opportunities in education, employment and entrepreneurship, today announced the winners of its fifth annual Startup Pitch Competition. The event, hosted by VetsinTech with presenting sponsor J.P. Morgan, showcased five early-stage startups

FairFigure, a leader in innovative business credit solutions, today announced the launch of FairFigure Lift, a first-of-its-kind business credit builder account that helps entrepreneurs build credit and access financing simultaneously – without a personal credit check. https://mma.prnewswire.com/media/2750929/Fairfigure_lift_product.jpg Unlike business credit cards, FairFigure Lift deposits credit-building funds directly into a business's bank account, providing immediate working

(NYSE:SOC), NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sable Offshore Corp. (NYSE: SOC): (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to Sable's May 21, 2025 secondary

Synergy Spine Solutions Inc., a leading innovator in artificial cervical disc replacement, today announced the appointment of Troy Wahlenmaier as Chief Commercial Officer (CCO). In this role, Mr. Wahlenmaier will lead global sales and marketing efforts as the company accelerates its growth and prepares for U.S. commercialization. https://mma.prnewswire.com/media/2092974/Synergy_Spine_Solutions_Logo.jpg With more than 30 years of commercial

ROSEN, THE FIRST FILING FIRM, Encourages Sable Offshore Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SOC GlobeNewswire August 14, 2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sable